Shunan Ruan

Evaluation of the efficacy and safety of intravenous remdesivir in adult patients with severe COVID-19: study protocol for a phase 3 randomized, double-blind, placebo-controlled, multicentre trial

Y. Liu, P. Horby, Y. Hu, 2020, Trials.

Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial

Yi Wang, Feng Wu, Yi Hu, 2020, The Lancet.

A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe Covid-19

Yuan Wei, Thomas Jaki, Bin Cao, 2020, The New England journal of medicine.

Risk Factors of Viral RNAaemia and Its Association With Clinical Prognosis Among Patients With Severe COVID-19

Ye-ming Wang, Xiaoying Gu, Hui Li, 2021, Chest.

Dynamic Changes of Antibodies to SARS-CoV-2 in COVID-19 Patients at Early Stage of Outbreak

P. Zhou, Hua-qing Shu, Hong Liu, 2020, Virologica Sinica.